• British American Tobacco increases stake in Canadian cannabis producer Organigram. British American Tobacco (BAT) has increased its stake in Canadian cannabis producer Organigram Holdings to 22.5%, deepening their partnership. The investment is worth CA$124.6 million ($92.5 million).
• Jazz Pharma considers selling cannabis arm, Ananda. Jazz Pharma is considering selling its cannabis arm, Ananda, which produces and sells CBD products. The move comes as Jazz Pharma focuses on its core business of developing and commercializing specialty pharmaceuticals.
• Phytovista Laboratories receives Informed Choice certification for CBD supplement. Phytovista Laboratories has received Informed Choice certification for its CBD supplement, Phytocannabinoid Rich Extract. The certification means that the product has been tested and verified to be free of banned substances.
• Swiss cannabis company Cannovum Cannabis AG expands into the UK. Swiss cannabis company Cannovum Cannabis AG is expanding into the UK market through a joint venture with British company Sativa Investments. The joint venture will focus on developing and commercializing medicinal cannabis products in the UK.
• Portugal grants 42 licenses for medicinal cannabis production. Portugal has granted 42 licenses for medicinal cannabis production, and another 150 are in the process. The move is part of Portugal’s efforts to become a major player in the global medicinal cannabis market.

1. British American Tobacco (BAT) has increased its stake in Canadian cannabis producer Organigram Holdings to 22.5% for CA$124.6 million ($92.5 million) ¹.
2. Jazz Pharma is considering selling its cannabis arm, Ananda, which produces and sells CBD products. The move comes as Jazz Pharma focuses on its core business of developing and commercializing specialty pharmaceuticals ².
3. Phytovista Laboratories has received Informed Choice certification for its CBD supplement, Phytocannabinoid Rich Extract. The certification means that the product has been tested and verified to be free of banned substances ³.
4. Swiss cannabis company Cannovum Cannabis AG is expanding into the UK market through a joint venture with British company Sativa Investments. The joint venture will focus on developing and commercializing medicinal cannabis products in the UK ⁴.
5. Portugal has granted 42 licenses for medicinal cannabis production, and another 150 are in the process. The move is part of Portugal’s efforts to become a major player in the global medicinal cannabis market ⁵.

Learn more:

1. cannabishealthnews.co.uk2. news.sky.com3. news.sky.com4. news.sky.com5. abc.net.au